Kelly Barfield

Kelly Barfield has extensive experience in the pharmaceutical industry. Kelly is currently working as the Director of National Accounts & Access Strategy at Deciphera Pharmaceuticals since May 2022. Prior to this, they worked as a Field Access Director at the same company from February 2020 to February 2022.

Before joining Deciphera Pharmaceuticals, Kelly was employed at HEMA Biologics as a Corporate Account Director from March 2017 to February 2020. Their responsibilities in this role included managing corporate accounts.

Kelly also gained valuable experience at Novo Nordisk, where they worked as a BioPharm Account Executive from September 2014 to March 2017. In this position, they handled regional payer management and distribution of Novo Nordisk's biopharmaceutical portfolio for California, Nevada, and Hawaii.

Prior to their role at Novo Nordisk, Kelly worked at Salix Pharmaceuticals as a Western Regional Account Manager from April 2011 to December 2013. Their responsibilities included managing commercial and managed Medicaid regional payers in multiple states and therapeutic areas.

Kelly began their career at Stiefel Laboratories as a Sales Representative from April 2003 to July 2009, where they gained experience in the pharmaceutical sales field. Before that, they worked at IKON Office Solutions as a Sales Representative from July 2002 to April 2003.

Overall, Kelly Barfield has a strong background in pharmaceutical sales, account management, and access strategy, with significant experience in managing corporate accounts and regional payer responsibilities.

Kelly Barfield attended California State University San Marcos from 2000 to 2002, where they pursued a degree in Business with a specialization in Finance.